A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer

Weidong Han(Sir Run Run Shaw Hospital), Hangxiang Wang(Ministry of Public Health)
Signal Transduction and Targeted Therapy
June 20, 2018
Cited by 98


Related Papers